Chokeberry extract enhances cytotoxicity of gemcitabine on a single cancer cell line, according to research.
Malignant melanoma was differentiated from benign skin lesions with high accuracy in a pivotal clinical utility study of the Myriad myPath Melanoma test.
Many young adults with the most common form of acute lymphoblastic leukemia (ALL) have a high-risk subtype with a poor prognosis and could benefit from drugs used to treat other types of leukemia.
High rates of preserved sexual function seen with combination beam plus brachytherapy for prostate cancer.
Mammograms for those aged 69 to 75 could result in over-treatment, researchers caution.
About 14.5 million U.S. cancer survivors are alive today, but aging population and increasing obesity threaten progress.
For patients with advanced esophageal cancer, dysphagia is improved with radiotherapy alone, according to a study.
Scientists have developed a tool to distinguish each breast cancer subtype, research that could improve treatments and targeting of treatments for the disease.
Shorter time to testosterone recovery with 18 versus 36 months androgen deprivation therapy.
More than 25% of hospital medicine services were rated by ordering physicians as at least a partially defensive order, according to recent data.
Adoptive T-cell therapy, a type of immunotherapy, appears to recognize unique cancer mutations that stimulate immune responses.
A new lung screening service for persons at high risk for lung cancer with incorporates a same-day visit by a nurse practitioner after the patient undergoes low-dose CT to discuss test results and recommendations.
Although nurses are familiar with palliative care guidelines related to cancer anorexia-cachexia syndrome, a needs-assessment survey revealed they are less familiar with novel therapeutic interventions in development.
Burnout was reduced and secondary trauma improved by a 6-week initiative to prevent compassion fatigue.
Pre- and postimplementation surveys are effective tools to confirm staff understanding of and adherence to a new neurologic assessment process for patients receiving high-dose cytarabine.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|